Pharmacotherapy Home




Wiederhold, Nathan, Pharm.D.
Adjoint Associate Professorship of Pharmacotherapy
210- 567-8355


Dr. Nathan Wiederhold joined the Division of Pharmacotherapy as an assistant professor in the fall of 2004. He received his B.A. in biology and his Pharm.D. from The University of Texas at Austin followed by pharmacy practice and an infectious diseases residencies at Barnes-Jewish Hospital in St. Louis. Upon finishing his clinical training, Dr. Wiederhold completed a research fellowship in antifungal pharmacology at the University of Houston and the University of Texas M.D. Anderson Cancer Center under the supervision of Russell Lewis, Dimitrios Kontoyiannis, and Randall Prince. His area of work during this fellowship was studying pharmacokinetic/pharmacodynamic parameters associated with antifungal efficacy with a primary focus on the echinocandin class of antifungals against Aspergillus and Candida species, and the cellular response of these organisms to this class of agents.

More information about Dr. Wiederhold
> Publications
> Abstracts
> Return to Dr. Wiederhold's Home Page

Last Reviewed: October 18, 2010

Division Information

Mailing Address:
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX

Email Address: pharmacy


Reveles Traces Rate of Hospital Infections

Dr. Kelly Reveles, assistant professor of pharmacotherapy, is primary author of a study which found that the incidence of Clostridium difficile infection (CDI), a highly contagious gastrointestinal disease often linked to the overprescribing of antibiotics, nearly doubled between 2001 and 2010. It also determined there were no improvements in patient health outcomes, including mortality or hospital length of stay, over the study period.

Read more about Reveles' study.

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z